tiprankstipranks
MaxCyte (MXCT) (GB:MXCT)
:MXCT
UK Market

MaxCyte (MXCT) Income Statement

Compare
9 Followers

MaxCyte Income Statement

Last quarter (Q3 2024), MaxCyte's total revenue was $8.16M, an increase of 1.99% from the same quarter last year. In Q3, MaxCyte's net income was $-11.56M. See MaxCyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 41.29M$ 44.26M$ 33.89M$ 26.17M$ 21.62M
Gross Profit
$ 36.55M$ 39.16M$ 30.25M$ 23.40M$ 19.12M
Operating Expenses
$ 84.84M$ 66.52M$ 48.44M$ 34.46M$ 31.54M
Depreciation and Amortization
$ 4.17M$ 2.70M$ 1.42M$ 1.05M$ 613.50K
EBITDA
$ -44.13M$ -20.87M$ -16.76M$ -9.94M$ -11.60M
Operating Income
$ -48.30M$ -27.36M$ -18.19M$ -11.06M$ -12.42M
Other Income/Expenses
$ 10.38M$ 3.79M$ -893.60K$ -759.70K$ -475.00K
Pretax Income
$ -37.92M$ -23.57M$ -19.08M$ -11.82M$ -12.89M
Net Income
$ -37.92M$ -19.78M$ -20.13M$ -12.64M$ -13.58M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.37$ -0.19$ -0.22$ -0.18$ -0.24
Diluted EPS
$ -0.37$ -0.19$ -0.22$ -0.18$ -0.24
Weighted Average Shares Outstanding
103.27M 101.70M 90.62M 69.46M 56.40M
Weighted Average Shares Outstanding (Diluted)
103.27M 101.70M 90.62M 69.46M 56.40M
Currency in USD

MaxCyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis